Literature DB >> 10221892

Commercial use of Burkholderia cepacia.

J J LiPuma, E Mahenthiralingam.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10221892      PMCID： PMC2640709          DOI： 10.3201/eid0502.990226

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


× No keyword cloud information.
  5 in total

Review 1.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Energy-generating enzymes of Burkholderia cepacia and their interactions with macrophages.

Authors:  Vasu Punj; Rachna Sharma; Olga Zaborina; A M Chakrabarty
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

3.  Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing.

Authors:  Adam Baldwin; Eshwar Mahenthiralingam; Pavel Drevinek; Chris Pope; David J Waine; Deborah A Henry; David P Speert; Phil Carter; Peter Vandamme; John J LiPuma; Chris G Dowson
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

4.  Infective endocarditis due to Burkholderia cepacia in a neonate: a case report.

Authors:  Emir Yonas; Vito Damay; Raymond Pranata; Nuvi Nusarintowati
Journal:  J Med Case Rep       Date:  2018-05-08

5.  Environmental Burkholderia cepacia complex isolates in human infections.

Authors:  Adam Baldwin; Eshwar Mahenthiralingam; Pavel Drevinek; Peter Vandamme; John R Govan; David J Waine; John J LiPuma; Luigi Chiarini; Claudia Dalmastri; Deborah A Henry; David P Speert; David Honeybourne; Martin C J Maiden; Chris G Dowson
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.